How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

4,439 results for

Congenital Heart Disease Imaging in Adults

by
...
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

161. Valvular Heart Disease: Guidelines For the Management of Patients With

have been proposed, based on current natural history studies of patients with VHD. The present document applies to adult patients with VHD. Management of patients with congenital heart disease and infants and children with valve disease are not addressedhere.Thedocumentrecommendsacombination of lifestyle modi?cations and medications that constitute GDMT. Both for GDMT and other recommended drug treatment regimens, the reader is advised to con?rm dos- ages with product insert material (...) for the Management of Adults With Congenital Heart Disease ACC/AHA 2008 (7) Echocardiographic Assessment of Valve Stenosis: EAE/ASE Recommendations for Clinical Practice EAE/ASE 2009 (8) Recommendations for Evaluation of Prosthetic Valves With Echocardiography and Doppler Ultrasound ASE 2009 (9) Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy ACCF/AHA 2011 (10) Guidelines on the Management of Cardiovascular Diseases During Pregnancy ESC 2011 (11) Antithrombotic and Thrombolytic Therapy

2014 American College of Cardiology

162. Diagnosis and Treatment of Fetal Cardiac Disease Full Text available with Trip Pro

on Jump to Free Access article Diagnosis and Treatment of Fetal Cardiac Disease A Scientific Statement From the American Heart Association , MD , MD , MD , MD , MD , MD , MD , MD , MD , MD , DO , MD , MD , RN , MD, DSc, FAHA , MD, FAHA , MD , and MD MDon behalf of the American Heart Association Adults With Congenital Heart Disease Joint Committee of the Council on Cardiovascular Disease in the Young and Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and Council (...) on Cardiovascular and Stroke Nursing Mary T. Donofrio , Anita J. Moon-Grady , Lisa K. Hornberger , Joshua A. Copel , Mark S. Sklansky , Alfred Abuhamad , Bettina F. Cuneo , James C. Huhta , Richard A. Jonas , Anita Krishnan , Stephanie Lacey , Wesley Lee , Erik C. MichelfelderSr , Gwen R. Rempel , Norman H. Silverman , Thomas L. Spray , Janette F. Strasburger , Wayne Tworetzky , and Jack Rychik and on behalf of the American Heart Association Adults With Congenital Heart Disease Joint Committee of the Council

2014 American Heart Association

163. 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease

the following ACC committees and councils: Adult Congenital and Pediatric Cardiology Section, Association of International Gover- nors, Council on Clinical Practice, Cardiovascular Section Leadership Council, Geriatric Cardiology Section Lead- ership Council, Heart Failure and Transplant Council, Interventional Council, Lifelong Learning Oversight Committee, Prevention of Cardiovascular Disease Com- mittee, and Surgeon Council). Reviewers’ RWI informa- tion was distributed to the writing committee (...) , 2) medical therapy, and 3) intervention. The purpose of these sub- sections was to categorize the COR according to the clinical decision-making pathways that caregivers use in the management of patients with VHD. New recom- mendations for assessment of the severity of valve lesions have been proposed, based on current natural history studies of patients with VHD. The present document applies to adult patients with VHD. Management of patients with congenital heart disease and infants and children

2014 Society for Cardiovascular Angiography and Interventions

164. Management of Heart Failure (4th Edition)

underlying causes of HF in adults are: ? Coronary artery disease (CAD) ? Hypertension ? Dilated cardiomyopathy-idiopathic, familial ? Valvular heart disease ? Diabetic cardiomyopathy Other causes of HF include: ? Congenital heart disease ? Cor pulmonale ? Pericardial disease: constrictive pericarditis, cardiac tamponade ? Hypertrophic cardiomyopathy ? Viral myocarditis ? Acute rheumatic fever 5. AETIOLOGY ? Toxic: Alcohol, cardiotoxic chemotherapy e.g. doxorubicin, trastuzumab (Herceptin (...) are: ? Coronary artery disease (CAD) ? Hypertension ? Dilated cardiomyopathy-idiopathic, familial ? Valvular heart disease ? Diabetic cardiomyopathy Other causes of HF include: ? Congenital heart disease ? Cor pulmonale ? Pericardial disease: constrictive pericarditis, cardiac tamponade ? Hypertrophic cardiomyopathy ? Viral myocarditis ? Acute rheumatic fever ? Toxic: Alcohol, cardiotoxic chemotherapy e.g. doxorubicin, trastuzumab (Herceptin), cyclophosphamide. ? Endocrine and metabolic disorders: thyroid

2019 Ministry of Health, Malaysia

165. 2019 ACC/AHA/ASE Key Data Elements and Definitions for Transthoracic Echocardiography: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Cardiovascular Endpoints D Full Text available with Trip Pro

on Clinical Data Standards (Writing Committee to Develop Clinical Data Standards for Cardiac Imaging). Circulation . 2009 ; 119:154–86. International Society for Nomenclature of Paediatric and Congenital Heart Disease. International Paediatric and Congenital Cardiac Code. Available at: . Accessed October 25, 2018. Lang RM, Badano LP, Mor-Avi V, et al. . Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European (...) in heterogeneous nomenclature and definitions across the spectrum of congenital heart diseases. In an effort to bridge these frequently competing classification systems, the International Society for Nomenclature of Pediatric and Congenital Heart Disease developed the International Pediatric and Congenital Cardiac Code ( ), a comprehensive list of congenital cardiovascular malformations that contains >1 000 diagnostic terms related to pediatric and congenital cardiac disease and cross-maps the terms from

2019 American Heart Association

166. Museum of TMH Multimodality Imaging Center: Congenital aplasia of the left iliac vein in a patient with concomittant sturge-weber syndrome and may-thurner syndrome with congenital aberrant left femoral to right greater saphenous vein bypass Full Text available with Trip Pro

syndrome and May-Thurner syndrome with congenital aberrant left femoral to right greater saphenous vein bypass. 49 Cheema Zulfiqar F ZF Methodist DeBakey Heart & Vascular Center, The Methodist Hospital, Houston, Texas, USA. Lumsden Alan B AB eng Case Reports Journal Article United States Methodist Debakey Cardiovasc J 101508600 1947-6108 IM Abnormalities, Multiple Adult Angiography, Digital Subtraction Endovascular Procedures instrumentation Femoral Vein abnormalities diagnostic imaging Humans Iliac (...) Museum of TMH Multimodality Imaging Center: Congenital aplasia of the left iliac vein in a patient with concomittant sturge-weber syndrome and may-thurner syndrome with congenital aberrant left femoral to right greater saphenous vein bypass 22891112 2012 12 27 2016 11 25 1947-6108 8 1 2012 Jan Methodist DeBakey cardiovascular journal Methodist Debakey Cardiovasc J Museum of TMH Multimodality Imaging Center. Congenital aplasia of the left iliac vein in a patient with concomittant Sturge-Weber

2012 Methodist DeBakey cardiovascular journal

167. ACR/SIR/SPR Practice Parameter for Specifications and Performance of Image-Guided Percutaneous Drainage/Aspiration of Abscesses and Fluid Collections (PDAFC)

, and treatment of disease. The variety and complexity of human conditions make it impossible to always reach the most appropriate diagnosis or to predict with certainty a particular response to treatment. Therefore, it should be recognized that adherence to the guidance in this document will not assure an accurate diagnosis or a successful outcome. All that should be expected is that the practitioner will follow a reasonable course of action based on current knowledge, available resources, and the needs (...) of the benefits, alternatives, and risks of the procedures. The physician must have a thorough understanding of imaging anatomy (including congenital and developmental variants), the imaging equipment to be used during the procedures, radiation safety considerations, and physiologic monitoring equipment. The physician must also have access to adequate supplies and personnel to perform the procedure safely. PDAFC procedures must be performed by a physician who has the following qualifications. The physician’s

2018 Society of Interventional Radiology

168. Optimal Use of Ionizing Radiation in Cardiovascular Imaging

with regard to childhood and teenage radiation exposure that tissue weighting factors do not take into account the increased sensitivity of the tissue of the pediatric population. Thus, for children and adolescents, a given radiation exposure confers a greater risk than the same exposure would confer to an adult population. In addition, children who do not have life threatening disorders have a long life expectancy, which provides a longer period for radiation-induced illness to present (13). 4.2 (...) Optimal Use of Ionizing Radiation in Cardiovascular Imaging EXPERT CONSENSUS DOCUMENT 2018 ACC/HRS/NASCI/SCAI/SCCT Expert Consensus Document on Optimal Use of Ionizing Radiation in Cardiovascular Imaging: Best Practices for Safety and Effectiveness A Report of the American College of Cardiology Task Force on Expert Consensus Decision Pathways Developed in Collaboration With Mended Hearts Writing Committee Members John W. Hirshfeld, JR, MD, FACC, FSCAI, Chair Victor A. Ferrari, MD, FACC, Co

2018 American College of Cardiology

169. Appropriate Use Criteria: Imaging of the Head & Neck

. These include: ¾ Oncologic imaging – Considerations include the type of malignancy and the point along the care continuum at which imaging is requested ¾ Conditions which span multiple anatomic regions – Examples include certain gastrointestinal indications or congenital spinal anomalies Repeated Imaging In general, repeated imaging of the same anatomic area should be limited to evaluation following an intervention, or when there is a change in clinical status such that imaging is required to determine next (...) the guidelines for specific imaging exams is a determination that the following are true with respect to the imaging request: ? A clinical evaluation has been performed prior to the imaging request (which should include a complete history and physical exam and review of results from relevant laboratory studies, prior imaging and supplementary testing) to identify suspected or established diseases or conditions. ? For suspected diseases or conditions: ? Based on the clinical evaluation, there is a reasonable

2018 AIM Specialty Health

170. Appropriate Use Criteria: Imaging of the Chest

-52.e75. 26. Ghaye B, Szapiro D, Dacher JN, et al. Percutaneous ablation for atrial fibrillation: the role of cross-sectional imaging. Radiographics. 2003;23:S19-S33. 27. Gilkeson RC, Ciancibello L, Zahka K. Multidetector CT evaluation of congenital heart disease in pediatric and adult patients. AJR Am J Roentgenol. 2003;180(4):973-980. 28. Hansell DM, Bankier AA, MacMahon H, McLoud TC, Müller NL, Remy J. Fleischner Society: glossary of terms for thoracic imaging. Radiology. 2008;246(3):697-722 (...) , depending on the specific clinical indication. Technology Considerations ? In the majority of clinical situations, chest radiographs should be performed prior to advanced imaging with CT, preferably within 30 days of the chest CT exam request. ? CT chest is not appropriate for cardiac and coronary artery imaging. Please see guidelines for cardiac CT and CCTA. ? When the purpose of the study is imaging of the heart, including the coronary arteries, do not request both a chest CT and a dedicated cardiac

2018 AIM Specialty Health

171. Appropriate Use Criteria: Imaging of the Abdomen & Pelvis

. These include: ¾ Oncologic imaging – Considerations include the type of malignancy and the point along the care continuum at which imaging is requested ¾ Conditions which span multiple anatomic regions – Examples include certain gastrointestinal indications or congenital spinal anomalies Repeated Imaging In general, repeated imaging of the same anatomic area should be limited to evaluation following an intervention, or when there is a change in clinical status such that imaging is required to determine next (...) the guidelines for specific imaging exams is a determination that the following are true with respect to the imaging request: ? A clinical evaluation has been performed prior to the imaging request (which should include a complete history and physical exam and review of results from relevant laboratory studies, prior imaging and supplementary testing) to identify suspected or established diseases or conditions. ? For suspected diseases or conditions: ? Based on the clinical evaluation, there is a reasonable

2018 AIM Specialty Health

172. Canadian Cardiovascular Society/Canadian Heart Rhythm Society Joint Position Statement on the Cardiovascular Screening of Competitive Athletes Full Text available with Trip Pro

screening in athletes: differing views from two sides of the Atlantic. Heart . 2018 ; 104 : 1037–1043 The resting 12-lead ECG is superior to the history and physical examination in the detection of disease associated with SCD. x 13 Harmon, K.G., Zigman, M., and Drezner, J.A. The effectiveness of screening history, physical exam, and ECG to detect potentially lethal cardiac disorders in athletes: a systematic review/meta-analysis. J Electrocardiol . 2015 ; 48 : 329–338 Factors considered in recommending (...) . A prospective study of sudden cardiac death among children and young adults. N Engl J Med . 2016 ; 374 : 2441–2452 , x 30 Pilmer, C.M., Porter, B., Kirsh, J.A. et al. Scope and nature of sudden cardiac death before age 40 in Ontario: a report from the cardiac death advisory committee of the office of the chief coroner. Heart Rhythm . 2013 ; 10 : 517–523 One might argue that PPS might lead to a diagnosis of heart disease, and the provision of advice regarding vigorous physical activity that might reduce

2018 Canadian Cardiovascular Society

173. Lonsurf (trifluridine / tipiracil) - adult patients with metastatic colorectal cancer (CRC)

Lonsurf (trifluridine / tipiracil) - adult patients with metastatic colorectal cancer (CRC) 30 Churchill Place ? Canary Wharf ? London E14 5EU ? United Kingdom An agency of the European Union Telephone +44 (0)20 3660 6000 Facsimile +44 (0)20 3660 5520 Send a question via our website www.ema.europa.eu/contact 25 February 2016 EMA/CHMP/287846/2016 Committee for Medicinal Products for Human Use (CHMP) Assessment report Lonsurf International non-proprietary name: trifluridine / tipiracil Procedure (...) study report CTCAE: Common Terminology Criteria for Adverse Events CV: Coefficient of variation CYP: Cytochrome P450 DCR: Disease control rate DNA: Deoxyribonucleic acid DPD: Dihydropyridine dehydrogenase DR: Duration of response EC: European Commission ECG: Electrocardiogram ECOG: Eastern Cooperative Oncology Group eCRF: Electronic case report form EGFR: Epidermal growth factor receptor EMA: European medicines agency EP: European Pharmacopoeia EU: European Union EMA/CHMP/287846/2016 Page 5/106 FAS

2016 European Medicines Agency - EPARs

174. The 2016 International Society for Heart Lung Transplantation listing criteria for heart transplantation: A 10-year update

, published in 2006. 1 Subsequently, the ISHLT commissioned a focused update to concentrate on evolving areas of importance, not fully addressed previously. These include congenital heart disease (CHD), restrictive cardiomyopathy, and infectious diseases. In addition, we undertook a review of all 2006 guidelines to update those where new information was evident or evolution in practice demanded signi?cant changes. Section I (general considerations): A review and revision of the 2006 guideline All (...) of diagnostic right-heart catheterization Right heart catheterization (RHC) should be performed on all candidates in preparation for listing for cardiac transplantation and annually until transplantation (Class 1, Level of Evidence: C). Right heart catheterization (RHC) should be performed on all adult candidates in preparation for listing for cardiac transplantation and periodically until transplantation (Class 1, Level of Evidence: C). Periodic RHC is not advocated for routine surveillance in children

2016 International Society for Heart and Lung Transplantation

175. Heart Failure Full Text available with Trip Pro

. Strong FOR Low Invasive coronary angiography should be considered in patients with heart failure associated with refractory angina, resuscitated cardiac arrest, sustained ventricular arrhythmias, or with evidence of ischaemic heart disease on other investigations, or an intermediate-to-high pretest probability for coronary artery disease, to determine the need for coronary revascularisation. Strong FOR Low Either computed tomography (CT) coronary angiography or cardiac magnetic resonance imaging (CMR (...) receptor neprilysin inhibitor; AV, atrioventricular; BNP, B-type natriuretic peptide; BP, blood pressure; bpm, beats per minute; CABG, coronary artery bypass graft; CMR, cardiac magnetic resonance imaging; CRT, cardiac resynchronisation therapy; CT, computed tomography; ECG, electrocardiogram; DCM, dilated cardiomyopathy; GRADE, Grading of Recommendations Assessment, Development and Evaluation; HFrEF, heart failure with reduced ejection fraction; ICD, implantable cardioverter defibrillator; LGE, late

2018 Cardiac Society of Australia and New Zealand

176. Evaluation and Management of Right-Sided Heart Failure

, is associated with poor clinical outcomes independently of the underlying mechanism of disease: across the spectrum of left ventricular (LV) ejection fraction (EF) in patients with acute and chronic heart failure (HF), after cardiac surgery, acute myocardial infarction (MI), congenital heart disease (CHD), and PH. To distinguish right-sided HF (RHF) from structural RVD, we define RHF as a clinical syndrome with signs and symptoms of HF resulting from RVD. RHF is caused by the inability of the RV to support (...) of right-sided heart failure (RHF) include, among others, primary cardiomyopathies with right ventricular (RV) involvement, RV ischemia and infarction, volume loading caused by cardiac lesions associated with congenital heart disease and valvular pathologies, and pressure loading resulting from pulmonic stenosis or pulmonary hypertension from a variety of causes, including left-sided heart disease. Progressive RV dysfunction in these disease states is associated with increased morbidity and mortality

2018 International Society for Heart and Lung Transplantation

177. AIM Clinical Appropriateness Guidelines for Diagnostic Coronary Angiography

such as SCORE or Framingham); OR ? Congenital heart disease with suspected coexistent CAD and either of the following ? To exclude coexistent atheromatous CAD in patients undergoing surgical repair of congenital heart disease who have moderate or high risk of CAD (SCORE); OR ? To evaluate patients with suspected congenital anomalous coronary artery abnormalitiesDiagnostic Coronary Angiography | Copyright © 2018. AIM Specialty Health. All Rights Reserved. 7 References 1. American College of Cardiology (...) al. ACC/AHA Guidelines for coronary angiography: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee on Coronary Angiography). Developed in collaboration with the Society for Cardiac Angiography and Interventions. J Am Coll Cardiol. 1999; 33(6):1756-1824. 10. Shaw LJ, Peterson ED, Shaw LK, et al. Use of a prognostic treadmill score in identifying diagnostic coronary disease subgroups. Circulation. 1998; 98(16):1622–30. 11. Warnes

2018 AIM Specialty Health

178. ACC/AHA/HRS Guideline on the Evaluation and Management of Patients With Bradycardia and Cardiac Conduction Delay

. Evaluation of Conduction Disorders 86 7.5. Management of Conduction Disorders (With 1:1 Atrioventricular Conduction) 92 8. Special Populations 95 8.1. Perioperative Management 95 8.1.1. Patients at Risk for Bradycardia During Noncardiac Surgery or Procedures 95 8.1.2. Postoperative Bradycardia and Conduction Disorders After Cardiac Surgery 96 8.2. Bradycardia Management for Adult Congenital Heart Disease 107 8.3. Management of Bradycardia in Patients With an Acute MI 109 8.4. Neurologic Disorders 111 (...) ) Expert consensus statement on the diagnosis and treatment of postural tachycardia syndrome, inappropriate sinus tachycardia, and vasovagal syncope HRS 2015 (S1.4-20) Expert consensus statement on the recognition and management of arrhythmias in adult congenital heart disease PACES/HRS 2014 (S1.4-21) Expert consensus statement on the use of implantable cardioverter-defibrillator therapy in patients who are not included or not well represented in clinical trials HRS/ACC/AHA 2014 (S1.4-22) Expert

2018 American College of Cardiology

179. Interdisciplinary Models for Research and Clinical Endeavors in Genomic Medicine: A Scientific Statement From the American Heart Association

to cardiovascular medicine—cardiac repolarization, blood lipid levels, and coronary artery disease—were reported in 2006 and 2007 and were followed in the ensuing years by the reporting of GWASs for numerous cardiovascular traits and diseases. Two considerations have made it imperative to recruit large study populations, often numbering >100 000 individuals, to perform these GWASs. First, common DNA variants by their nature typically make only small contributions to clinical phenotypes; that is, they have small (...) to a large degree, comparable to rare variants responsible for mendelian disorders (several-fold increase in risk). For example, a genomic risk score comprising 50 DNA variants associated with coronary artery disease separated individuals in the top quintile versus those in the bottom quintile of the score by 1.91-fold difference in risk of incident coronary events. Furthermore, DNA variants identified by GWASs tend to lie in noncoding regions of the genome, making it less clear which genes

2018 American Heart Association

180. Interventions to Improve the Labour Market Situation of Adults with Physical and/or Sensory Disabilities in Low? and Middle?Income Countries: A Systematic Review Full Text available with Trip Pro

and structures, often identified as symptoms or signs of health conditions (i.e., diseases, injuries, and disorders). 2 As such, the terms ‘impairment’ and ‘health condition’ are often used interchangeably (a practice adopted in this review). The following additional definitions and restrictions also apply. Definitions . Physical impairment is defined as problems with the structure, development, or function of the bones, muscles, joints, and/or central nervous system. Physical characteristics may include (...) of participants with the following types of health condition/physical impairments were eligible for the review: communicable diseases (e.g., leprosy); metabolism disorders (e.g., diabetes); respiratory conditions (e.g., asthma); neurological impairments (e.g., multiple sclerosis, epilepsy, those associated with brain injury); musculoskeletal conditions (e.g., arthritis, amputations); cardiovascular diseases; and body disfigurements (e.g., burn injuries). For sensory impairments, eligibility for the review

2015 Campbell Collaboration

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>